1. Home
  2. BLLN vs KFY Comparison

BLLN vs KFY Comparison

Compare BLLN & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$80.12

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo Korn Ferry

KFY

Korn Ferry

HOLD

Current Price

$62.91

Market Cap

3.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
KFY
Founded
2016
1969
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.4B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
BLLN
KFY
Price
$80.12
$62.91
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$129.57
$71.33
AVG Volume (30 Days)
318.7K
532.8K
Earning Date
03-04-2026
03-09-2026
Dividend Yield
N/A
3.11%
EPS Growth
N/A
42.41
EPS
N/A
3.84
Revenue
N/A
$1,819,519,000.00
Revenue This Year
$45.89
$7.14
Revenue Next Year
$30.17
$3.32
P/E Ratio
N/A
$16.13
Revenue Growth
N/A
12.20
52 Week Low
$61.96
$58.27
52 Week High
$138.70
$78.50

Technical Indicators

Market Signals
Indicator
BLLN
KFY
Relative Strength Index (RSI) 54.69 51.58
Support Level $63.98 $62.46
Resistance Level $86.01 $64.35
Average True Range (ATR) 5.61 1.79
MACD 1.30 0.19
Stochastic Oscillator 75.47 68.02

Price Performance

Historical Comparison
BLLN
KFY

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

Share on Social Networks: